Home
Leadership
Science
Data
Media
- News
- Videos
Partners
Contact

Listen to our founder and CEO, Lewis Gruber discuss SIWA and 318H!

Home / Uncategorized / Listen to our founder and CEO, Lewis Gruber discuss SIWA and 318H!

02Apr 2021 by Andrew Premovich

Search for:

Recent Posts

New antibody shows strong potential against pancreatic cancer
SIWA Therapeutics, Inc. Presents New Data at the November 2022 American Association for Cancer Research Aging and Cancer Conference
SIWA Therapeutics Announces Promising Results in New Pancreatic Cancer Study
SIWA Therapeutics, Inc. Appoints Deborah Wince-Smith to Board of Directors
Listen to Ashley Jensen discuss SIWA’s antibody at AACR’s Virtual Conference!

Archives

October 2023
November 2022
March 2022
February 2022
October 2021
April 2021
October 2020
September 2020
June 2020
May 2020
March 2020
February 2020
September 2019
March 2019
April 2018
June 2017
May 2017
October 2016

Categories

Events
In The News
News
Press Releases
Publications
Uncategorized

About Us

SIWA’s 318H monoclonal antibody targets a biomarker on cancer cells and senescent cells. Our initial focus is on life-threatening cancers and related diseases with an unmet medical need (i.e., eligible for FDA Fast-tracking)

Recent News

New antibody shows strong potential against pancreatic cancer
SIWA Therapeutics, Inc. Presents New Data at the November 2022 American Association for Cancer Research Aging and Cancer Conference
SIWA Therapeutics Announces Promising Results in New Pancreatic Cancer Study

JOIN OUR MAILING LIST

Navigation

Home
Leadership
Science
Data
Media
- News
- Videos
Partners
Contact